Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01988675 : MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patients receiving partial brain irradiation for malignant or benign brain tumors
(including low-grade gliomas, high-grade gliomas, malignant meningioma, pituitary
adenomas, supratentorial meningioma, or craniopharyngiomas); or patients receiving
whole brain irradiation for brain metastases.

- Patients must be 18 years of age or older

- Patients must sign a study specific consent form approved by the Institutional Review
Board (IRB) of the University of Michigan prior to study entry.

- Patients must have a neurological function class 1 or 2 with a Karnofsky performance
status (a scoring system used to quantify general well being and quality of life on a
scale of 100 to 0) of greater than or equal to 70.

- Patients must have an expected life expectancy of greater than 6 months.

Exclusion Criteria:

- Patients with a history of major medical illness or psychiatric impairment which, in
the investigator's opinion, will prevent administration of the protocol.

- Patients who have had prior external beam irradiation to the brain or head/neck area
that will lead to overlap of the radiation field.

- Patients should have no contraindications to having a contrast enhanced Magnetic
Resonance Imaging (MRI) scan.

- Prisoners are excluded.

- Pregnant women are excluded.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT01988675      |      Link to official Clinicaltrials.gov listing
Locations
Ann Arbor, Michigan
Facility: University of Michigan Hosptial
Investigator: Yue Cao, Ph.D.
Contact: Yue Cao, Ph.D. Phone: 734-936-8695
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites